Management of the unknown primary in patients wiht metastatic cancer of the head and neck

Ear, Nose and Throat Journal

Volumn 79, Issue 4, 2000, Pages 306-313

  Gabalski, Edward C ^a,b   Belles, William ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Berks ENT Surgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BIOPSY; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRACTICE GUIDELINE; SQUAMOUS CELL CARCINOMA;

EID: 0034054293     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130007900418     Document Type: Article

References (19)

1. Martin H, Romieu C. The diagnostic significance of a "lump in the neck.". Postgrad Med 1952;11:491-500.
2. Winegar LK, Griffin W. The occult primary tumor. Arch Otolaryngol 1973;98:159-63.
3. McGuirt WF. The unknown primary in metastatic head and neck cancer, a clinical approach. N C Med J 1978:39:299-300.
4. Martin H, Morfit HM. Cervical lymph node metastasis as the first symptom of cancer Surg Gynecol Obstet 1944:78:133-59.
5. Coker DD, Casterline PF, Chambers RG, Jaques DA. Metastases to lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977;134:517-22.
6. Fried MP, Diehl WH Jr., Brownson RJ, et al. Cervical metastasis from an unknown primary. Ann Otol Rhinol Laryngol 1975;84:152-7.
7. MacComb WS. Diagnosis and treatment of metastatic cervical cancerous nodes from an unknown primary site. Am J Surg 1972;124:441-9.
8. Gluckman JL. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a 5-year experience Laryngoscope 1991;101:36-42.
9. Lore JM. An Atlas of Head and Neck Surgery. 3rd ed Philadelphia: W B. Saunders, 1988
10. Marchelta FC, Sako K, Camp F. Multiple malignancies in patients with head and neck cancer. Am J Surg 1965;110:537-41.
11. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992;21:160-3.
12. Caspersson T, Santesson L. Studies on protein metabolism in the cells of epithelial tumors. Acta Radiol 1942;46:17-8.
13. Richart RM. A clinical test for the in vivo delineation of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1963;86:703-12.
14. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45:328-51.
15. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan® toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996;25:97-103.
16. McGuirt WF. Differential diagnosis of neck masses. In: Cummings CW, Schuller DE, eds. Otolaryngology - Head and Neck Surgery. Vol. 2, 2nd ed. St. Louis: Mosby-Year Book, 1993
17. Righi PD, Sofferman RA. Screening unilateral tonsillectomy in the unknown primary Laryngoscope 1995;105:548-50.
18. Thawley SE, O'Leary M. Malignant neoplasms of the oropharynx. In: Cummings CW, Schuller DE, eds. Otolaryngology-Head and Neck Surgery. Vol. 2, 2nd ed. St. Louis: Mosby-Year Book, 1993.
19. Mendenhall WM, Million RR, Bova FJ. Analysis of time-dose factors in clinically positive neck nodes treated with irradiation alone in squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1984;10:639-43.